Interesting....
So the only company that attended conferences recently was RDGL. We know that George is/was an advisor for RDGL. RDGL has a pending de novo application with the FDA for human clinical testing.
Maybe, RDGL will be split into two, partnering with GRDO, whereupon GRDO takes the human cancer device, with the pending approval, leaving RDGL the animal aspect of their cancer therapy. That would match up as to this cryptic tweet about a NEW BIOTECH coming.
IF, a big IF, that were the case. Then GRDO would GO TO SILVER.
HMMMMMMMMMMMMM
Market Data 
Markets 
AI
